Use of thromboxane a2 receptor antagonist for the prevention or mitigation of adverse side effects of protamine

摘要

A method is provided for preventing, reducing or reversing adverse reactions, such as pulmonary hypertension produced when protamine interacts with heparin, by administering a thromboxane A2 receptor antagonist.